Genmab | GEN - Assets

Stock Price
2,097.00
Daily Change
7.00 0.33%
Monthly
4.33%
Yearly
51.08%
Q1 Forecast
1,920.90

Genmab reported DKK6.46B in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Agios Pharmaceuticals USD 1.39B 85.53M Sep/2025
Almirall EUR 2.31B 88.74M Jun/2025
Amarin USD 659.81M 10.31M Sep/2025
Amgen USD 90.14B 2.24B Sep/2025
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Demant DKK 39.07B 6.43B Dec/2025
Exelixis USD 2.82B 145.47M Sep/2025
Fresenius Medical Care EUR 30.89B 404.18M Sep/2025
Galapagos EUR 3.51B 306.31M Sep/2025
Genmab DKK 6.46B 122M Jun/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
GN Store Nord DKK 29.06B 436M Sep/2025
GRIFOLS EUR 19.85B 86.61M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Insmed USD 2.36B 119.12M Sep/2025
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 50.93B 3.58B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 17.35B 1.72B Dec/2024